本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

65.22
-0.4900-0.75%
盤前65.220.00000.00%04:01 EDT
成交量:103.54萬
成交額:6,738.47萬
市值:61.48億
市盈率:-136.89
高:65.80
開:65.78
低:63.71
收:65.71
52周最高:66.38
52周最低:17.05
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.78
換手率:1.12%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:250.70
市盈率(LYR):-227.76

資料載入中...

2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/09

重要事件披露

Form 8-K - Current report
2026/06/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities